These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 16690350)

  • 21. Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population.
    Baasland I; Romundstad PR; Eide ML; Jonassen CM
    PLoS One; 2019; 14(1):e0210997. PubMed ID: 30673759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV testing in primary screening of older women.
    Cuzick J; Beverley E; Ho L; Terry G; Sapper H; Mielzynska I; Lorincz A; Chan WK; Krausz T; Soutter P
    Br J Cancer; 1999 Oct; 81(3):554-8. PubMed ID: 10507785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women.
    Bigras G; de Marval F
    Br J Cancer; 2005 Sep; 93(5):575-81. PubMed ID: 16136031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of variable methods for HPV testing].
    Cheng JY; Bian ML; Ma L; Cong X; Chen Y; Liu J
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):589-94. PubMed ID: 24199924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease.
    Carozzi F; Bisanzi S; Sani C; Zappa M; Cecchini S; Ciatto S; Confortini M
    J Clin Microbiol; 2007 Feb; 45(2):364-9. PubMed ID: 17122008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
    Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
    [No Abstract]   [Full Text] [Related]  

  • 27. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
    Kaufman RH; Adam E; Icenogle J; Reeves WC
    Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples.
    Munoz M; Camargo M; Soto-De Leon SC; Sanchez R; Parra D; Pineda AC; Sussmann O; Perez-Prados A; Patarroyo ME; Patarroyo MA
    PLoS One; 2013; 8(2):e56509. PubMed ID: 23418581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience of Combined Liquid Based Cervical Cytology and High-Risk HPV mRNA for Cervical Cancer Screening in Thammasat University Hospital.
    Muangto T; Chanthasenanont A; Lertvutivivat S; Nanthakomon T; Pongrojpaw D; Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2016; 17(9):4409-4413. PubMed ID: 27797253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A paired comparison of dot blot hybridization and PCR amplification for HPV testing of cervical scrapes interpreted as CIN 1.
    Duggan MA; Inoue M; McGregor SE; Stuart GC; Morris S; Chang-Poon V; Schepansky A; Honore L
    Eur J Gynaecol Oncol; 1994; 15(3):178-87. PubMed ID: 7957322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the performance of Human Papillomavirus testing in paired urine and clinician-collected cervical samples among women aged over 30 years in Bhutan.
    Tshomo U; Franceschi S; Tshokey T; Tobgay T; Baussano I; Tenet V; Snijders PJ; Gheit T; Tommasino M; Vorsters A; Clifford GM
    Virol J; 2017 Apr; 14(1):74. PubMed ID: 28390433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular detection of human papillomavirus in 594 uterine cervix samples from Moroccan women (147 biopsies and 447 swabs).
    Amrani M; Lalaoui K; El Mzibri M; Lazo P; Belabbas MA
    J Clin Virol; 2003 Aug; 27(3):286-95. PubMed ID: 12878093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of human papillomavirus DNA detection in samples obtained for routine Chlamydia trachomatis screening.
    Söderlund-Strand A; Wikström A; Dillner J
    J Clin Virol; 2015 Mar; 64():88-91. PubMed ID: 25728085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program.
    Lazcano-Ponce E; Lörincz AT; Salmerón J; Fernández I; Cruz A; Hernández P; Mejia I; Hernández-Avila M
    Cancer Causes Control; 2010 Oct; 21(10):1693-700. PubMed ID: 20617376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions.
    Clavel C; Masure M; Levert M; Putaud I; Mangeonjean C; Lorenzato M; Nazeyrollas P; Gabriel R; Quereux C; Birembaut P
    Diagn Mol Pathol; 2000 Sep; 9(3):145-50. PubMed ID: 10976721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus testing for primary screening in women at low risk of developing cervical cancer. The Greek experience.
    Agorastos T; Dinas K; Lloveras B; de Sanjose S; Kornegay JR; Bonti H; Bosch FX; Constantinidis T; Bontis J
    Gynecol Oncol; 2005 Mar; 96(3):714-20. PubMed ID: 15721416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPV detection and measurement of HPV-16, telomerase, and survivin transcripts in colposcopy clinic patients.
    Lanham S; Herbert A; Watt P
    J Clin Pathol; 2001 Apr; 54(4):304-8. PubMed ID: 11304848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Risk HPV Testing in Primary Screening for Cervical Cancer in the Public Health System, São Paulo, Brazil.
    Levi JE; Martins TR; Longatto-Filho A; Cohen DD; Cury L; Fuza LM; Villa LL; Eluf-Neto J
    Cancer Prev Res (Phila); 2019 Aug; 12(8):539-546. PubMed ID: 31189569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.
    Perrons C; Kleter B; Jelley R; Jalal H; Quint W; Tedder R
    J Med Virol; 2002 Jun; 67(2):246-52. PubMed ID: 11992586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.